Moderna Capitalizes On Its Headstart In COVID-19 Vaccines
Leaked List Shows Premium Price Secured With EU
The US biotech has booked orders of nearly 500 million doses for its COVID-19 vaccine, and a leaked price list from Europe shows it has secured a premium price ahead of all its rivals, including Pfizer/BioNTech.
